Story perspectives
FDA Rejection Sparks Urgency for Rare Disease Treatments
7/8/2025
50 11
1 of 1
Story summary
- US drug regulators are pushing for quicker approvals for rare diseases, yet patients like Hope Filchak with ultra-rare conditions still struggle. The FDA's rejection of elamipretide, a promising treatment for mitochondrial disorders, raises concerns among advocates about the drug's fate and the urgent needs of patients. Hope's mother remains a steadfast voice for her daughter's fight.
